Modulation of TREM2 by CD33: a protein QTL study integrates Alzheimer loci in human monocytes

View/ Open
Author
Chan, Gail
White, Charles C.
Winn, Phoebe A.
Cimpean, Maria
Replogle, Joseph M.
Glick, Laura R.
Cuerdon, Nicole E.
Schneider, Julie A.
Bennett, David A.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/nn.4126Metadata
Show full item recordCitation
Chan, G., C. C. White, P. A. Winn, M. Cimpean, J. M. Replogle, L. R. Glick, N. E. Cuerdon, et al. 2015. “Modulation of TREM2 by CD33: a protein QTL study integrates Alzheimer loci in human monocytes.” Nature neuroscience 18 (11): 1556-1558. doi:10.1038/nn.4126. http://dx.doi.org/10.1038/nn.4126.Abstract
Here, we report results from a protein quantitative trait analysis in monocytes from 226 individuals to evaluate cross-talk between Alzheimer loci. We find that the NME8 locus influences PTK2B and that the CD33 risk allele leads to greater TREM2 expression. Further, we observe (1) a decreased TREM1/TREM2 ratio with a TREM1 risk allele, (2) decreased TREM2 expression with CD33 suppression, and (3) elevated cortical TREM2 mRNA expression with amyloid pathology.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682915/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320444
Collections
- HMS Scholarly Articles [17714]
- SPH Scholarly Articles [6329]
Contact administrator regarding this item (to report mistakes or request changes)